You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,528,086


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,528,086
Title: Methods and apparatus for drug delivery involving phase changing formulations
Abstract:This invention relates to an apparatus and method of drug delivery on a human body surface. The formulation comprises a drug, a conversion agent capable of converting the formulation from a less solid phase to a coherent, soft, solid phase, and a vehicle medium or carrier for the drug and conversion agent. The drug formulation is applied to this human body surface in its less than solid phase and is subsequently converted to a soft solid phase while the drug is being delivered through the human body surface. After delivery of the drug is complete, the soft solid formulation can be removed or peeled from the body surface as a coherent solid formulation. The drug formulation provides control over drug delivery rates and allows the formulation to be removed without leaving a messy, residual formulation on the body surface.
Inventor(s): Zhang; Jie (Salt Lake City, UT)
Assignee: Zars, Inc. (Salt Lake City, UT)
Application Number:09/407,720
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing exclusive rights to inventors and companies for their creations. To navigate the complex landscape of patents, it is crucial to understand the scope and claims of a patent. This article will delve into the specifics of U.S. Patent 6,528,086, using it as a case study to explain the broader concepts of patent scope, claims, and the patent landscape in the United States.

What is a Patent?

A patent is a form of intellectual property that grants the owner the right to exclude others from making, using, selling, and importing the invention for a certain period, usually 20 years from the filing date. Patents are governed by the U.S. Patent and Trademark Office (USPTO) and are subject to the conditions and requirements of the Patent Act[2].

Patent Scope

The scope of a patent is defined by its claims, which are the legal descriptions of the invention. The scope determines what is protected and what is not. A broader scope can provide more extensive protection but may also increase the risk of infringement litigation and challenges to the patent's validity[3].

Metrics for Measuring Patent Scope

Researchers often use metrics such as independent claim length and independent claim count to measure patent scope. These metrics can indicate the breadth and clarity of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Claims

Patent claims are the heart of a patent, outlining what the inventor considers to be the novel and non-obvious aspects of the invention. There are two main types of claims: independent claims and dependent claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are crucial because they set the boundaries of what is protected by the patent.

Dependent Claims

Dependent claims refer back to an independent claim and further limit the scope of the invention. They often provide additional details or variations of the invention.

U.S. Patent 6,528,086: A Case Study

While the specific details of U.S. Patent 6,528,086 are not provided in the sources, we can use general principles to analyze its scope and claims.

Claim Construction

The construction of claims is a critical step in understanding the patent's scope. This process involves interpreting the language of the claims to determine their meaning and application. Courts often engage in claim construction to resolve disputes over patent infringement, as seen in cases like Contour IP Holding LLC v. GoPro, Inc.[2].

Patent Ineligibility

Claims must also pass the test of patent eligibility under 35 U.S.C. ยง 101. This involves determining whether the claims are directed to abstract ideas, laws of nature, or natural phenomena, which are not patentable. The Alice test is a two-step process used to evaluate this eligibility[2].

The Patent Landscape in the United States

Patent Search and Documentation

The USPTO provides various tools for searching and accessing patent documentation. The Global Dossier, for example, allows users to view the file histories of related applications from participating IP Offices. The Public Search Facility and Patent and Trademark Resource Centers (PTRCs) also offer resources for conducting thorough patent searches[1].

Patent Infringement Litigation

Patent infringement litigation is a significant aspect of the patent landscape. Factors such as the volume and characteristics of litigation, the types of patents in dispute, and judicial developments can all impact the likelihood and outcome of such litigation. Non-practicing entities (NPEs) often play a role in these lawsuits, which can affect the overall patent ecosystem[4].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address the high costs and complexities associated with patent litigation. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes, particularly for small inventors and businesses[5].

Tools and Resources for Patent Analysis

Global Dossier

The Global Dossier provides a single portal for accessing the file histories of related patent applications from participating IP Offices. This tool is invaluable for understanding the global patent family and tracking office actions and citations[1].

Common Citation Document (CCD)

The CCD consolidates prior art citations from multiple IP Offices, allowing users to visualize the search results for the same invention on a single page. This helps in assessing the novelty and non-obviousness of the invention[1].

Patent Examination Data System (PEDS)

PEDS allows users to search, view, and download bibliographic data for all publicly available patent applications. This system is useful for analyzing the examination process and the scope of patent claims[1].

Challenges and Debates in Patent Scope and Claims

Patent Quality

There is ongoing debate about the quality of patents, with concerns over the breadth and clarity of claims. Broader claims can lead to increased licensing and litigation costs, potentially diminishing incentives for innovation[3].

Judicial Developments

Judicial decisions, such as those related to the Alice test, continue to shape the landscape of patent eligibility and the construction of claims. These developments can significantly impact the validity and enforceability of patents[2].

Key Takeaways

  • Patent Scope: Defined by the claims, which determine what is protected and what is not.
  • Claim Construction: Critical for understanding the patent's scope and resolving disputes.
  • Patent Eligibility: Claims must pass the Alice test to ensure they are not directed to abstract ideas or other non-patentable subject matter.
  • Patent Search Tools: Resources like the Global Dossier, CCD, and PEDS are essential for analyzing and understanding patents.
  • Patent Litigation: Factors such as NPEs and judicial developments can significantly impact the patent landscape.

FAQs

Q: What is the purpose of the Global Dossier?

The Global Dossier is a service that provides access to the file histories of related patent applications from participating IP Offices, helping users to track and analyze the global patent family.

Q: How do independent and dependent claims differ?

Independent claims stand alone and define the invention, while dependent claims refer back to an independent claim and further limit the scope of the invention.

Q: What is the Alice test?

The Alice test is a two-step process used to determine whether patent claims are directed to abstract ideas or other non-patentable subject matter.

Q: Why is patent scope important?

Patent scope is crucial because it determines the extent of protection provided by the patent and can impact the likelihood of infringement litigation and the validity of the patent.

Q: What is the role of Non-Practicing Entities (NPEs) in patent litigation?

NPEs, which do not make products but own patents, often engage in patent litigation to assert their patents for profit, which can affect the overall patent ecosystem.

Sources

  1. USPTO: Search for patents - USPTO.
  2. CAFC: CONTOUR IP HOLDING LLC v. GOPRO, INC.
  3. SSRN: Patent Claims and Patent Scope.
  4. GAO: Assessing Factors That Affect Patent Infringement Litigation.
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,528,086

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,528,086

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 345757 ⤷  Subscribe
Australia 7719800 ⤷  Subscribe
Canada 2386017 ⤷  Subscribe
China 100367927 ⤷  Subscribe
China 101219108 ⤷  Subscribe
China 1376043 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.